DoubleChecks

What was claimed

My plan to cure autoimmune gastritis using experimental steps including mapping immune cells and building 'Bryan in a dish' - no one has ever done this to try and cure an autoimmune disease

Our verdict

Needs Caution

This is too absolute and conflicts with the literature, which already discusses experimental immune-targeting and tolerance-restoring strategies for autoimmune gastritis and other autoimmune conditions. The provided sources show related attempts in preclinical settings, so the claim of "no one" is not supported. The provided sources do not identify or describe this exact plan or this specific model. I cannot confirm the wording or the novelty of the named approach from these sources alone.

2 of 3 AI systems agree7 sources citedChecked Jul 9, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

No one has ever used immune-cell mapping and patient-specific 'in-a-dish' models to try to cure an autoimmune disease.

Incorrect90%
All 3 AIs agree

The plan involves experimental steps such as mapping immune cells and building a "Bryan in a dish" model.

Can’t verify60%
1 AI checked

Mapping immune cells is part of an experimental approach to autoimmune gastritis

Verified85%
1 AI checked

Building 'organs in a dish' (organoids) is being explored for autoimmune disease treatment

Verified90%
1 AI checked

Immune-cell targeting approaches for autoimmune gastritis remain experimental or preclinical.

Verified95%
1 AI checked

Autoimmune gastritis has no established cure.

Verified96%
1 of 2 AIs agree·Claude: Misleading

Verified against 7 sources

frontiersin.orgpmc.ncbi.nlm.nih.govthebloodproject.comrupahealth.commerckmanuals.comautoimmuneinstitute.orgsciencedirect.com

Detailed Analysis

The claim is partly accurate but overstated. Current reviews say autoimmune gastritis still has no established cure, and experimental approaches such as immune-cell targeting remain preclinical or conceptual [2] [3] [5]. However, the assertion that “no one has ever done this” is not verifiable from the provided sources and is too absolute, because the literature already describes experimental immune-modulating strategies in autoimmune gastritis models [1] [2].

Why this verdict

  • The claim is partly accurate but overstated.
  • Current reviews say autoimmune gastritis still has no established cure, and experimental approaches such as immune-cell targeting remain preclinical or conceptual [2] [3] [5].
  • However, the assertion that “no one has ever done this” is not verifiable from the provided sources and is too absolute, because the literature already describes experimental immune-modulating strategies in autoimmune gastritis models [1] [2].

Claims checked

No one has ever tried this to cure an autoimmune disease.

Incorrect92%
This is too absolute and conflicts with the literature, which already discusses experimental immune-targeting and tolerance-restoring strategies for autoimmune gastritis and other autoimmune conditions [1] [2] [3]. The provided sources show related attempts in preclinical settings, so the claim of "no one" is not supported.

This claim may mislead readers without added context.

The plan involves experimental steps such as mapping immune cells and building a "Bryan in a dish" model.

Can’t verify60%
The provided sources do not identify or describe this exact plan or this specific model. I cannot confirm the wording or the novelty of the named approach from these sources alone.

Immune-cell targeting approaches for autoimmune gastritis remain experimental or preclinical.

Verified95%
Current reviews describe immunomodulatory strategies such as restoring Treg function or low-dose IL-2 as experimental, with no clinical trials yet conducted in AIG for those approaches [2] [3].

What other AI think

The claim contains a mix of accurate and misleading elements. While organoid technology and immune cell mapping are real experimental approaches being researched for autoimmune diseases, the claim that "no one has ever done this to try and cure an autoimmune disease" is inaccurate. Organoid-based approaches for autoimmune disease research and treatment are actively being studied, though clinical applications remain limited.

Why this verdict

  • The claim contains a mix of accurate and misleading elements.
  • While organoid technology and immune cell mapping are real experimental approaches being researched for autoimmune diseases, the claim that "no one has ever done this to try and cure an autoimmune disease" is inaccurate.
  • Organoid-based approaches for autoimmune disease research and treatment are actively being studied, though clinical applications remain limited.

Claims checked

No one has ever done this to try and cure an autoimmune disease

Incorrect85%
Organoid-based approaches and immune cell mapping are already being researched for autoimmune disease treatment. iPSCs-derived organoids have been transplanted in animal models for MS, IBD, and type 1 diabetes. Immune organoids are positioned at the forefront of autoimmune disease modeling and immunotherapy development.

This claim may mislead readers without added context.

This is a plan to cure autoimmune gastritis

Misleading80%
The approach is experimental and exploratory, not a proven cure. Current medical consensus is that there is no approved cure for autoimmune gastritis; treatment focuses on management rather than cure.

This claim may mislead readers without added context.

Mapping immune cells is part of an experimental approach to autoimmune gastritis

Verified85%
Research shows immune cell characterization is central to understanding autoimmune gastritis pathogenesis, and mapping immune cells is a recognized research strategy for autoimmune diseases.
The statement that “no one has ever done this” is factually incorrect. Researchers have used immune-cell mapping and patient-derived 'disease-in-a-dish' models to study and attempt therapies for autoimmune diseases.

Why this verdict

  • The statement that “no one has ever done this” is factually incorrect.
  • Researchers have used immune-cell mapping and patient-derived 'disease-in-a-dish' models to study and attempt therapies for autoimmune diseases.

Claims checked

No one has ever used immune-cell mapping and patient-specific 'in-a-dish' models to try to cure an autoimmune disease.

Incorrect92%
Single-cell immune mapping and patient-derived organoids or 'disease-in-a-dish' approaches have been applied to autoimmune diseases for mechanistic study and to guide therapeutic strategies, so the absolute claim that no one has ever tried this is incorrect.

This claim may mislead readers without added context.

Share this result

Try DoubleChecks